LOL.
Thanks for misquoting me and taking what I say out of context.
Just as a reality check (egos are another continent in your case) how about the reality that the legal system is built on a dialectic.
But, - I emphasise this point - strategic thinkers (this does not exclude lawyers who take instructions from their clients but also collaborate on strategy) do not go the litigation route as the first step. These days it's mandated anyway but I digress.
Good strategists (this does not exclude lawyers, remember?) cover themselves but they will try negotiation and every possible avenue before going in with guns blazing. There is also the look of the thing. Or the optics as we say nowadays.
If you failed to comprehend this after my emphasising it so many times, I wonder where the fault is?
Also I don't know why you're in here baiting away all day, never making a significant or substantive contribution, but if you imagine you're successfully emulating PJK I will leave you to your vanities and delusions.
- Forums
- ASX - By Stock
- MSB
- MSB to dispute FDA finding in Type A meeting
MSB to dispute FDA finding in Type A meeting, page-588
-
- There are more pages in this discussion • 430 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.17 |
Change
-0.025(2.10%) |
Mkt cap ! $1.330B |
Open | High | Low | Value | Volume |
$1.18 | $1.22 | $1.15 | $6.344M | 5.404M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 8683 | $1.16 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.17 | 32999 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 8683 | 1.155 |
7 | 295447 | 1.150 |
3 | 70786 | 1.145 |
6 | 196386 | 1.140 |
3 | 75486 | 1.135 |
Price($) | Vol. | No. |
---|---|---|
1.165 | 32999 | 1 |
1.170 | 62618 | 6 |
1.175 | 48590 | 3 |
1.180 | 79079 | 4 |
1.185 | 17090 | 2 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online